S&P 500 Futures
(-0.08%) 5 304.25 points
Dow J Futures
(-0.09%) 40 140 points
Nasdaq Futures
(-0.05%) 18 465 points
Oil
(-0.07%) $83.11
Gas
(-0.62%) $1.752
Gold
(0.73%) $2 254.80
Silver
(0.74%) $25.10
Platinum
(0.21%) $923.00
USD/EUR
(0.16%) $0.928
USD/NOK
(0.19%) $10.86
USD/GBP
(0.02%) $0.792
USD/RUB
(-0.38%) $92.23

Realtime updates for Groupe Actiplay SA [ALACT.PA]

Exchange: EURONEXT Industry: Advertising Agencies
Last Updated28 Mar 2024 @ 12:14

-2.73% 3.21

Live Chart Being Loaded With Signals

Commentary (28 Mar 2024 @ 12:14):

Warning: Trying to access array offset on null in /home/getagraph/public_html/stock.php on line 302

Acticor Biotech SAS operates as a clinical stage biotechnology company that develops drugs for the treatment of acute phase of thrombotic diseases. The company develops glenzocimab, a humanized monoclonal antibody fragment that targets a specific platelet glycoprotein...

Stats
Today's Volume 4 463.00
Average Volume 21 500.00
Market Cap 50.57M
EPS €0 ( 2023-10-26 )
Last Dividend €0 ( N/A )
Next Dividend €0 ( N/A )
P/E -1.920
ATR14 €0.0160 (0.50%)

Groupe Actiplay SA Correlation

10 Most Positive Correlations
10 Most Negative Correlations

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Groupe Actiplay SA Financials

Annual 2022
Revenue: €0
Gross Profit: €-86 000.00 (0.00 %)
EPS: €-1.580
Q2 2023
Revenue: €0
Gross Profit: €-7 000.00 (0.00 %)
EPS: €-0.870
Q1 2023
Revenue: €0
Gross Profit: €0 (0.00 %)
EPS: €-0.440
Q4 2022
Revenue: €0
Gross Profit: €-50 000.00 (0.00 %)
EPS: €-0.810

Financial Reports:

No articles found.

Groupe Actiplay SA

Acticor Biotech SAS operates as a clinical stage biotechnology company that develops drugs for the treatment of acute phase of thrombotic diseases. The company develops glenzocimab, a humanized monoclonal antibody fragment that targets a specific platelet glycoprotein. It is also involved in two clinical programs in Phase II/III registration for the treatment of ischemic stroke; and two other Phase II trials addressing major cardiovascular emergencies with clinical results expected in ischemic stroke and Covid-19 respiratory distress syndrome. The company was incorporated in 2013 and is headquartered in Paris, France.

About Live Signals

The live signals presented on this page help determine when to BUY or SELL NA. The signals have upwards of a 1-minute delay; like all market signals, there is a chance for error or mistakes.

The live trading signals are not definite, and getagraph.com hold no responsibility for any action taken upon these signals, as described in the Terms of Use. The signals are based on a wide range of technical analysis indicators